Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Alopecia Areata: early-phase trial registry
15 of 27 indexed Alopecia Areata trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #598 of 28,707 conditions by registered trial count.
27 US clinical trials · 15 currently recruiting · #598 of 28,707 conditions by registered trial count
Alopecia Areata: 27 US clinical trials tracked, 15 recruiting.
Alopecia Areata is the subject of 27 registered US clinical trials on ClinicalTrials.gov, 15 of them currently open to new participants. 5 are in Phase 3-4 (later-stage) and 15 in Phase 1-2 (earlier-stage). The most active sponsor is Pfizer, running 3 of these trials.
Enrollment posture brief
Registry condition alopecia-areata
OPEN 15 | RECR 56% | LATE 5 | EARLY 15 | RANK #598 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Acute Lymphoblastic Leukemia, Pediatric (56% recruiting · 9 trials)
Alopecia Areata lists 15 open slots (56% of 27 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Alopecia Areata on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Alopecia Areata is recruiting above its size-band peers.
15 of 27 indexed trials (55.6%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Alopecia Areata trials is spread across many organizations.
Pfizer accounts for 3 of 27 trials (11.1%). 21 distinct sponsors appear on at least one study for this condition label.
-
Typical Alopecia Areata enrolment sits around 94 participants.
Median target enrolment is 94 among the 27 trials that report a genuine target (sentinel values excluded). 14 of those (51.9%) plan for fewer than 100 participants.
-
Alopecia Areata research is mostly interventional.
20 interventional and 7 observational studies make up this index (74.1% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
27 total, page 1 of 1
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Sanguine Biosciences
NCT05635266
CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry
CorEvitas
NCT05745389
CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry
CorEvitas
NCT06562270
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
AbbVie
NCT06012240
Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib
Pfizer
NCT06531109
A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
Pfizer
NCT06873945
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Sun Pharmaceutical Industries
NCT07133308
A Study of LAD603 in Adults With Alopecia Areata
Almirall, S.A.
NCT07311564
A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo
Dren Bio
NCT06602232
Dupilumab in the Treatment of Pediatric Alopecia Areata
Icahn School of Medicine at Mount Sinai
NCT05866562
Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata
National Institute of Allergy and Infectious Diseases (NIAID)
NCT05398809
Regeneron AA Multicenter (Dupilumab)
Emma Guttman
NCT05551793
Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome
Icahn School of Medicine at Mount Sinai
NCT07242638
Evaluation of Microbiota Transplant Therapy in Patients With Alopecia Areata
University of Minnesota
NCT06747611
Intralesional Cyclosporine for Alopecia Areata
University of California, Davis
NCT07029204
A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC
Target PharmaSolutions
NCT03661866
Alopecia Areata Registry
M.D. Anderson Cancer Center
NCT00069589
Long-Term PF-06651600 for the Treatment of Alopecia Areata
Pfizer
NCT04006457
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata
Sun Pharmaceutical Industries
NCT03898479
A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Adult Participants With Severe Alopecia Areata
Sanofi
NCT06444451
A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Severe to Very Severe Alopecia Areata in Adult Patients (Rezolve AA)
Nektar Therapeutics
NCT06340360
A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)
Q32 Bio
NCT06018428
Aldara for the Treatment of Extensive Alopecia Areata
Hordinsky, Maria K., MD
NCT00177021
Pilot Study to Evaluate the Efficacy of Ruxolitinib in Alopecia Areata
Columbia University
NCT01950780
Study To Evaluate The Efficacy Of Tofacitinib In Moderate To Severe Alopecia Areata, Totalis And Universalis
Columbia University
NCT02299297
A Study of Vitamin D in Subjects With Alopecia Areata
Avera McKennan Hospital & University Health Center
NCT01328678
Open Label Study of ATI-50002 Topical Solution Administered to Adult Subjects With Eyebrow Loss Due to Alopecia Areata
Aclaris Therapeutics
NCT03551821
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 13 |
| Phase 3 | 4 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Alopecia Areata records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Alopecia Areata trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Alopecia Areata page
27 registered trials, 15 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 15 Alopecia Areata trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Pfizer sponsors the most Alopecia Areata trials on record, review their full trial history before evaluating a specific study. See Pfizer's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Alopecia Areata condition card totals 27 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.